The Food and Drug Administration (FDA) has released a warning to consumers about the dangers of the drug Benicar (olmesartan medoxomil), Benicar HCT, Triobenzor and Azor. The warning comes in response to reports of severe gastrointestinal (GI) conditions resulting from prolonged use of Benicar. Conditions include development of sprue-like enteropathy, characterized by chronic diarrhea and substantial weight loss.
Celiac sprue, also known as celiac disease, gluten-sensitive enteropathy, and gluten-induced enteropathy, is a chronic disease of the digestive tract that interferes with the digestion and absorption of nutrients from food.
Benicar users may also suffer from villous atrophy – a disorder causing the intestinal lining to lose it’s texture, making it impossible for the person to absorb nutrients from the food ingested. This condition is followed rapidly by cases of malnourishment, which can lead to other gastrointestinal complications.
Side Effects of Benicar, Benicar HCT, Triobenzor and Azor display themselves much the same way as celiac disease, and is commonly misdiagnosed as such. Celiac disease is a sensitivity to gluten, a protein commonly found it wheat. The symptoms of celiac disease involve the gluten damaging the lining of the intestines, causing digestion and absorption problems.
If you or someone you know is experiencing severe chronic diarrhea and extreme weight loss after taking Benicar, you may be entitled to compensation from the manufacturers of the drug. If you contracted villous atrophy, or exhibit the symptoms of Benicar side effects, contact an experienced South Carolina Injury Attorney at the Stampfle Law Firm for a Free Consultation about your legal options.